Bruns Ingmar Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$45,656.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Bruns Ingmar

According to the SEC Form 4 filings, Bruns Ingmar, being in a position of

  1. Chief Medical Officer at Zentalis Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 3297 shares for $7,998,
    over all time since 2025-02-06, has bought 20000 shares for $45,656, and sold 3297 shares for $7,998.

Biography of Bruns Ingmar

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $7,9982100

Comparison of Insiders on Amount of Buys and Sells

2026-02-09SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Medical Officer
335
0.0005%
$2.39$802+54.17%
2026-02-06SaleZentalis Pharmaceuticals, Inc.
ZNTL
Chief Medical Officer
2,962
0.0042%
$2.43$7,197+54.39%
2025-02-06PurchaseZentalis Pharmaceuticals, Inc.
ZNTL
Chief Medical Officer
20,000
0.0299%
$2.28$45,656-31.94%
Total: 3
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.